slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 54,721-54,750
Pages 3,679
Rows per page 30
Component
54,721-54,750 of 110,355
08
Includes clinical trial data (101A/102A) for Arginase 1 Deficiency.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · NeedLoop · Pattern Hunter1 hit
11
The slide outlines a randomized controlled trial structure with an open-label extension.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
12
The slide uses a map to visualize patient prevalence estimates in specific addressable markets.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
18
Includes a Kaplan-Meier survival curve and a comparative table of clinical manifestations.Aeglea BioTherapeutics | Investor Presentation Deck | 22 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Pattern Hunter1 hit
10
The slide uses a waterfall chart to show license accumulation and a stacked area chart to show revenue contribution by license vintage.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
17
The chart uses a dual-axis approach to correlate financial metrics with headcount growth.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Financials1 hit
02
Includes date reference: June 13, 2022.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
05
The slide uses a hierarchical structure to connect a high-level objective to three distinct operational pillars.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a Gantt-style visualization to show drug development progress.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
10
The slide uses a split-layout: left side defines the condition and market size, right side outlines the clinical and regulatory pain points.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses chemical structures and bar charts to contrast the two enantiomers.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competition1 hit
14
CADSS = Clinician Administered Dissociative States Scale. Data points are plotted over time (Baseline, 15m, 40m, 90m).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
15
The slide uses a timeline diagram to illustrate the clinical trial phases.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
16
The table uses checkmarks to indicate positive attributes for specific compounds.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
18
Uses a vertical timeline-style process diagram to list unmet needs.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
20
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide highlights positive cognitive signals from a Phase 2 study, specifically emphasizing the efficacy of lower doses of RL-007.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The slide uses a combination of a list-based framework for the 'Massive Unaddressed Need' and a data-heavy section for 'Anxiety in numbers'.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
26
The slide uses a split-layout with a dark sidebar for key facts and a white main area for clinical data and trial design.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
27
The slide uses a checkmark matrix to highlight the competitive advantage of the company's lead asset against standard-of-care classes like SSRIs, SNRIs, and Benzodiazepines.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a map, metric callouts, and a vertical timeline-style list to quantify the market opportunity.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
31
The table uses checkmarks to indicate positive attributes for various therapies, highlighting DMX-1002's unique profile.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
33
The slide uses a Venn-like grouping of logos to illustrate the company's ecosystem.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
34
The slide uses a three-column layout to detail specific biotech subsidiaries/partnerships.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
38
Includes a list of institutional investors at the bottom.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
44
The slide highlights that RL-007 reverses memory deficits at the lowest dose and outperforms the standard of care (Aricept).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
46
The slide uses a split timeline to contrast early research with modern regulatory progress, punctuated by a Nixon quote.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
33
The chart illustrates cohort-based revenue growth over time.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations Beat · Action1 hit
36
The slide uses a circular flow diagram to represent a network effect or flywheel.The RealReal | Results Presentation Deck | 41 slides · The RealReal
Pitch deck Investor relations 1 hit